Victor Hogan
Impact in
- Immunology top 0.5%
- Galectins and Cancer Biology
- Toxin Mechanisms and Immunotoxins
- Molecular Biology top 2%
- Signaling Pathways in Disease
- Glycosylation and Glycoproteins Research
- Protein Tyrosine Phosphatases
Papers in
- Immunology 34
- Galectins and Cancer Biology 32
- Toxin Mechanisms and Immunotoxins 7
-
- Signaling Pathways in Disease 15
- Glycosylation and Glycoproteins Research 10
- Wnt/β-catenin signaling in development and cancer 6
- RNA modifications and cancer 4
- Co-authors
- Avraham RazPratima Nangia‐MakkerLarry TaitYuichiro HonjoYukinori TakenakaKenneth J. PientaTomoharu FukumoriTirza Raz
- Journals
- Cancer Research (14 papers)Journal of Biological Chemistry (5 papers)Oncotarget (5 papers)International Journal of Cancer (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesJapanIsrael
In The Last Decade
Victor Hogan
52 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 112
- Immunology 2.7k
- Molecular Biology 2.8k
- Oncology 933
- Cancer Research 410
- Cell Biology 300
Countries citing papers authored by Victor Hogan
This map shows the geographic impact of Victor Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Hogan more than expected).
Fields of papers citing papers by Victor Hogan
This network shows the impact of papers produced by Victor Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Hogan. The network helps show where Victor Hogan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Victor Hogan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 18 | |
| 2 | 2019 | 48 | |
| 3 | 2016 | 53 | |
| 4 | 2016 | 24 | |
| 5 | 2015 | 22 | |
| 6 | 2014 | 77 | |
| 7 | 2010 | 89 | |
| 8 | 2009 | 69 | |
| 9 | 2009 | 97 | |
| 10 | 2008 | 49 | |
| 11 | 2007 | 57 | |
| 12 | 2007 | 30 | |
| 13 | 2007 | 113 | |
| 14 | Inhibition of breast cancer progression by a medicinal herb Ocimum sanctum | 2006 | 2 |
| 15 | Inhibition of angiogenesis by a common herb: Ocimum sactum | 2004 | 1 |
| 16 | Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. | 2003 | 75 |
| 17 | 2002 | 24 | |
| 18 | 2000 | 97 | |
| 19 | 1993 | 80 | |
| 20 | 1990 | 151 |
About Victor Hogan
Victor Hogan is a scholar working on Immunology, Molecular Biology, Physiology, Cell Biology and Oncology, having authored 53 papers that have together received 4.4k indexed citations. Recurring topics across this work include Galectins and Cancer Biology (32 papers), Signaling Pathways in Disease (15 papers), Glycosylation and Glycoproteins Research (10 papers), Erythrocyte Function and Pathophysiology (10 papers), Toxin Mechanisms and Immunotoxins (7 papers), Wnt/β-catenin signaling in development and cancer (6 papers), Peptidase Inhibition and Analysis (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Immunology (2.7k citations), Molecular Biology (2.8k citations), Oncology (933 citations), Cancer Research (410 citations) and Cell Biology (300 citations). Victor Hogan has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include Avraham Raz, Pratima Nangia‐Makker, Larry Tait, Yuichiro Honjo, Yukinori Takenaka, Kenneth J. Pienta, Tomoharu Fukumori, Tirza Raz, Takashi Yanagawa and Tatsuyoshi Funasaka. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Oncotarget, International Journal of Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.